These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 744897

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Urinary kallikrein, aldosterone, prostaglandin E2, sodium, potassium, and urinary volume in normal man-interrelations and day to day variation.
    Ohman KP, Karlberg BE.
    Acta Med Scand Suppl; 1983; 677():30-5. PubMed ID: 6584001
    [No Abstract] [Full Text] [Related]

  • 23. Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat. Influence of mineralocorticoids.
    Nasjletti A, McGiff JC, Colina-Chourio J.
    Circ Res; 1978 Nov; 43(5):799-807. PubMed ID: 309362
    [Abstract] [Full Text] [Related]

  • 24. The prostaglandin and kallikrein-kinin systems in mineralocorticoid escape.
    Zipser RD, Zia P, Stone RA, Horton R.
    J Clin Endocrinol Metab; 1978 Nov; 47(5):996-1001. PubMed ID: 263798
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Role of renal kallikrein in the derangement of sodium and water excretion in cirrhotic patients.
    Hattori K, Hasumura Y, Takeuchi J.
    Scand J Gastroenterol; 1984 Sep; 19(6):844-8. PubMed ID: 6393317
    [Abstract] [Full Text] [Related]

  • 27. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
    Pérez-Ayuso RM, Arroyo V, Camps J, Rimola A, Costa J, Gaya J, Rivera F, Rodés J.
    Hepatology; 1984 Sep; 4(2):247-52. PubMed ID: 6368354
    [Abstract] [Full Text] [Related]

  • 28. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats.
    Yasujima M, Abe K, Tanno M, Sato K, Kasai Y, Seino M, Chiba S, Goto T, Omata K, Tajima J.
    Clin Exp Hypertens A; 1984 Sep; 6(7):1297-310. PubMed ID: 6565534
    [Abstract] [Full Text] [Related]

  • 29. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M, Abe K, Chiba S, Sato M, Irokawa N, Imai Y, Saito K, Sakurai Y, Ito T, Ritsu K, Haruyama T, Otsuka Y, Yoshinaga K.
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A, Wolff HP.
    Klin Wochenschr; 1979 Oct 01; 57(19):1037-45. PubMed ID: 392177
    [Abstract] [Full Text] [Related]

  • 32. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI, Matthews PG, Dax E.
    Clin Sci Mol Med Suppl; 1976 Dec 01; 3():283s-286s. PubMed ID: 1071628
    [Abstract] [Full Text] [Related]

  • 33. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
    Mackay IG, Nath K, Cumming AD, Muir AL, Watson ML.
    Clin Sci (Lond); 1985 Feb 01; 68(2):159-64. PubMed ID: 3881208
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term effects of aldosterone on kallikrein, prostaglandin E2 and sodium in rats.
    Yasujima M, Abe K, Tanno M, Kohzuki M, Kanazawa M, Omata K, Kasai Y, Sato M, Takeuchi K, Itoh S.
    Tohoku J Exp Med; 1987 Aug 01; 152(4):351-62. PubMed ID: 3477885
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
    Favre L, Jornot L, Riondel A, Vallotton M.
    Clin Exp Hypertens A; 1987 Aug 01; 7(12):1663-79. PubMed ID: 3869481
    [Abstract] [Full Text] [Related]

  • 38. The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs.
    Olsen UB, Arrigoni-Martelli E.
    Eur J Pharmacol; 1979 Mar 01; 54(3):229-34. PubMed ID: 218824
    [Abstract] [Full Text] [Related]

  • 39. Acute effects of MK421, a new angiotensin converting enzyme inhibitor, in man.
    Kasai Y, Abe K, Yasujima M, Tajima J, Seino M, Chiba S, Sato K, Goto T, Omata K, Tanno M.
    Tohoku J Exp Med; 1983 Dec 01; 141(4):417-22. PubMed ID: 6322384
    [Abstract] [Full Text] [Related]

  • 40. [The role of renal pressor and depressor substances (author's transl)].
    Abe K.
    Nihon Jinzo Gakkai Shi; 1979 Apr 01; 21(4):408-12. PubMed ID: 480717
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.